Moderna ( NASDAQ: MRNA) Q4 2024 Earnings Conference Call February 14, 2025 8:00 AM ET Lavina Talukdar - Senior Vice President, Investor Relations Stephane Bancel - Chief Executive Officer Jamey Mock - ...

Moderna Inc . (BMV:MRNA) reported its fourth-quarter earnings for 2024, revealing a significant decline in revenue and a net loss. The company's earnings per share (EPS) were lower than expected, and ...

Moderna (NASDAQ:MRNA) stock drops ~5% as its Q4 2024 results show revenue beat but earnings miss expectations. Read more here ...

By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.

The lab of Dr. Mark Magnuson, Louise B. McGavock Professor and professor of molecular physiology and biophysics at Vanderbilt ...

Background Increased pigmentation has been associated with cancer stem-cell-like behaviour and chemoresistance in uveal ...

Dinoflagellates play crucial roles in aquatic ecosystems, particularly as major contributors to harmful algal blooms. They ...

Protein synthesis is vital for life, translating genetic information from DNA to functional proteins through transcription ...

The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many ...

InDevR partners with Aldevron to describe how the VaxArray 5′CapQ assay can be used to measure intact mRNA in a single assay to streamline bioprocess development.

From being a promising yet underexplored approach in the 1990s, mRNA therapeutics have evolved dramatically. The discovery of chemical modifications to ove | Ebooks ...